Compare ONB & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONB | BIO |
|---|---|---|
| Founded | 1834 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 8.7B |
| IPO Year | N/A | N/A |
| Metric | ONB | BIO |
|---|---|---|
| Price | $22.79 | $318.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | $26.18 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 2.5M | 182.6K |
| Earning Date | 01-21-2026 | 02-12-2026 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | ★ 2.73 | N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | $2,110,915,000.00 | ★ $2,557,500,000.00 |
| Revenue This Year | $45.61 | $1.62 |
| Revenue Next Year | $14.54 | $2.26 |
| P/E Ratio | $13.33 | ★ N/A |
| Revenue Growth | ★ 20.70 | N/A |
| 52 Week Low | $16.83 | $211.43 |
| 52 Week High | $24.49 | $373.69 |
| Indicator | ONB | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 54.61 |
| Support Level | $22.51 | $316.57 |
| Resistance Level | $23.75 | $328.56 |
| Average True Range (ATR) | 0.51 | 7.95 |
| MACD | -0.08 | 1.60 |
| Stochastic Oscillator | 44.31 | 65.26 |
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.